P66Shc-Induced MicroRNA-34a Causes Diabetic Endothelial Dysfunction by Downregulating Sirtuin1

Area of Science:

• Vascular Biology
• Endocrinology
• Molecular Medicine

Background:

• Diabetes mellitus is characterized by vascular endothelial dysfunction.
• MicroRNA expression is altered in diabetic vasculature.
• Endothelial microRNA-34a (miR-34a) and Sirtuin1 (Sirt1) are implicated in diabetic vascular complications.

Purpose of the Study:

• To investigate the role of endothelial miR-34a in diabetic vascular dysfunction.
• To determine if miR-34a targets Sirt1 in the diabetic endothelium.
• To examine whether p66Shc regulates miR-34a expression in the diabetic endothelium.

Main Methods:

• Studied miR-34a and Sirt1 expression in diabetic mouse models (db/db, streptozotocin-induced).
• Utilized miR-34a inhibitors, endothelium-specific knockout models, and Sirt1 overexpression.
• Investigated high glucose and palmitate effects on endothelial cells in vitro, assessing oxidative stress and p66Shc involvement.

Main Results:

• MiR-34a was upregulated and Sirt1 downregulated in diabetic mouse endothelium.
• Inhibition of miR-34a or Sirt1 overexpression rescued diabetic vascular dysfunction.
• p66Shc mediated high glucose/palmitate-induced miR-34a upregulation via an oxidant-sensitive pathway.

Conclusions:

• Hyperglycemia and free fatty acids upregulate endothelial miR-34a through p66Shc and oxidative stress.
• This miR-34a upregulation targets Sirt1, causing endothelial dysfunction in diabetes.
• Targeting p66Shc or miR-34a may offer therapeutic strategies for diabetic vascular complications.